Registered Rwanda · Rwanda FDA

COCCIDIN

Sodium Fusidate

Rwanda FDA-HMP-MA-0038 Cream 2% w/w dermatologicals INN generic

What it does

Fusidate is an antibiotic used to treat bacterial infections on the skin.

Commonly used for: skin infections, bacterial skin infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-0038
Registration date
2020-11-14
Expiry date
2025-11-14
Status
Registered
Active ingredient
Sodium Fusidate
Dosage form
Cream
Strength
2% w/w
Pack size
15g
Therapeutic class
-
ATC class (WHO)
D06AX - Other antibiotics for topical use
Drug group
DERMATOLOGICALS
RxNorm RxCUI
113608
Manufacturer / MAH
Cooper Pharma
Applicant / LTR
LABORATOIRES COOPER PHARMA
Country of origin
MOROCCO
Manufacturer location
10 Rue Mohammed Diouri, Casablanca 20250, Morocco

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:40 · updated 2026-03-11 23:33:09

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About this medicine

Fusidate is an antibiotic used to treat bacterial infections on the skin.

What it treats

  • skin infections
  • bacterial skin infections

How it works

It works by stopping the growth of bacteria that cause infections.

Who it's for

Fusidate is suitable for adults and children with specific bacterial skin infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: fusidate

BNF-referenced

Fusidate, specifically fusidic acid, is an antibiotic used primarily for its effectiveness against gram-positive bacteria, particularly Staphylococcus aureus. It is often utilized in the treatment of skin infections, including impetigo and infected eczema, and can also be effective against osteomyelitis and endocarditis. Fusidate works by inhibiting bacterial protein synthesis, thus preventing the growth and replication of bacteria.

Indications

  • Impetigo
  • Infected eczema
  • Osteomyelitis
  • Endocarditis
  • Skin infections caused by Staphylococcus aureus

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines based on the child's age and weight.

Adults: Refer to the BNF for specific dosing guidelines based on the condition being treated.

Mechanism of action

Fusidate inhibits bacterial protein synthesis by binding to the elongation factor G (EF-G) in bacteria. This binding prevents the translocation step of protein synthesis, effectively halting bacterial growth. The primary action occurs in the ribosomal machinery of the bacteria, leading to the inhibition of peptide chain elongation.

Pharmacodynamics

Fusidate exhibits bacteriostatic activity against a range of gram-positive organisms, particularly those resistant to other antibiotics. Its efficacy is enhanced when used in combination with other antibiotics, particularly in treating mixed infections. The drug demonstrates a high degree of selective toxicity, as it primarily affects bacterial ribosomes.

Pharmacokinetics

Fusidate is well-absorbed following oral administration, with peak plasma concentrations typically reached within a few hours. The drug is extensively distributed throughout body tissues, particularly in bone and skin. Fusidate is metabolized in the liver, and its elimination is primarily through bile. The half-life of fusidate can vary, necessitating careful consideration in dosing, particularly in patients with liver impairment.

Adverse effects

  • Nausea
  • Diarrhea
  • Rash
  • Pruritus
  • Elevated liver enzymes

Precautions

  • Monitor liver function tests during prolonged therapy
  • Use with caution in patients with a history of liver disease

Pregnancy

Fusidate should only be used during pregnancy if clearly needed and after careful consideration of the risks and benefits.

Breast-feeding

Fusidate is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Topical cream
  • Topical ointment
  • Oral tablet

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: fusidate

PubChem CID 44123551

Molecular formula: C31H47O6-

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.